Stay updated on Pimavanserin in Impulse Control Disorders Clinical Trial
Sign up to get notified when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.

Latest updates to the Pimavanserin in Impulse Control Disorders Clinical Trial page
- Check5 days agoChange DetectedThe page history shows a new revision entry (Revision: v3.3.4) and removal of Revision: v3.3.3, which are minor metadata updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedThe page history shows an addition of Revision: v3.3.3 and deletions of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer area. These are site-wide updates and do not affect the study record, data, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedAdded revision v3.3.2 to the record history and removed revision v3.2.0.SummaryDifference0.1%

- Check63 days agoChange DetectedThe temporary government funding/operating-status notice at the top of the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check77 days agoChange DetectedThe history shows multiple version updates adding and revising study status, recruitment status, and contacts/locations, with later versions also introducing the IPDSharing field.SummaryDifference0.1%

- Check106 days agoChange DetectedUpdated version to v3.2.0 and added a government-operating-status notice; removed the prior v3.1.0 tag.SummaryDifference12%

Stay in the know with updates to Pimavanserin in Impulse Control Disorders Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pimavanserin in Impulse Control Disorders Clinical Trial page.